The National Institutes of Health (NIH) intends to award a one-year, firm fixed-price sole source contract to QuVa Pharma, Inc. for 503b compounded Intravenous (IV) Narcotics used in patient care at the NIH Clinical Center in Bethesda, MD 20892. This is a notice of intent, not a request for quotation, and no solicitation document will be issued. The decision to sole source is based on market research indicating QuVa is the only manufacturer and distributor of these specific IV narcotics in the U.S. Comments on this notice may be submitted to the contract specialist by May 6, 2026 at 9 am EST. No budget amount is specified in the description.